Hepatic alveolar echinococcosis-induced IL-23 maintains Th17/Treg homeostasis via the JAK2/STAT3 signaling pathway.
Abstract
Background
Alveolar echinococcosis (AE), caused by Echinococcus multilocularis (E.multilocularis), is a life-threatening zoonotic disease with limited therapeutic options, and reliable biomarkers of disease activity and immunotherapeutic targets are urgently needed. Although IL-23 has been linked to lesion metabolic activity in AE, its role in maintaining Th17/Treg homeostasis and whether this depends on JAK2/STAT3 signaling remain incompletely defined. Therefore, this study aimed to investigate the role of IL-23 in maintaining Th17/Treg homeostasis via the JAK2/STAT3 signaling pathway in patients with hepatic AE and in experimental models, and to assess its potential value as an immunotherapeutic target and as a biomarker of disease activity.
Methods
We performed bioinformatic analysis and collected multiple specimen types, including liver tissue and peripheral blood samples from patients with hepatic AE, E.multilocularis infected mice sacrificed at 4, 12 and 24 weeks post infection, and an in vitro cell co-culture system. The expression of IL-23 and Th17/Treg-related cytokines was measured by ELISA, IHC/IF, Western blot (WB) and flow cytometry (FCM). We further explored the functional role of the IL-23/IL-17 axis using JAK2 inhibitors, STAT3 inhibitors and agonists, as well as Kupffer cell conditional IL-23 knockout mice.
Results
Hepatic levels of IL-23 A, p-JAK2 and p-STAT3 were significantly higher in AE patients and E.multilocularis-infected mice. Serum IL-23 A concentrations were also elevated and showed a positive correlation with patients' PET-CT SUVmax values. E.multilocularis infection triggered robust IL-23 A production in Kupffer cells and increased expression of IL-17 A and RORγt. During infection, IL-23 A expression increased early, peaked at the middle stage, and decreased thereafter. Th17-related factors followed a comparable rise-and-fall pattern, while Treg-related factors kept rising, shifting Th17/Treg homeostasis from early-phase Th17 predominance toward late-phase Treg dominance. Inhibition of JAK2 or STAT3 reduced p-STAT3 and Th17 associated molecules and mildly upregulated Treg associated molecules, these effects were partially reversed by a STAT3 agonist. In Kupffer cell conditional IL-23 knockout mice, E.multilocularis infection resulted in increased metacestode burden and aggravated liver injury, accompanied by further suppression of Th17 responses, enhanced Treg responses, and reduced JAK2/STAT3 activation.
Conclusion
Our multiple lines of evidence support a working model whereby IL-23 sustains Th17/Treg homeostasis, at least in part, through the JAK2/STAT3 signaling pathway. IL-23 facilitates protective Th17 immune responses at the early infection stage and restrains excessive immunosuppression driven by dominant Treg cells during chronic infection. Conversely, IL-23 ablation disturbs this immune balance, which in turn further inhibits Th17 responses and amplifies Treg-mediated immunosuppression, ultimately increasing metacestode burdens and aggravating hepatic injury.